EDITORIAL: Antigenic Response to Ct-P13 and Infliximab Originator in Ibd Shows Similar Epitope Recognition-Evidence from Basic Science Supports Safe Switching to Biosimilars. Authors' Reply

AuthID
 P-00P-E38
5
Author(s)
Danese, S
·
Lakatos, PL
·
Ben Horin, S
Document Type
Editorial Material
Year published
2018
Published
in ALIMENTARY PHARMACOLOGY & THERAPEUTICS, ISSN: 0269-2813
Volume: 48, Issue: 5, Pages: 575-576 (2)
Indexing
Wos®
Scopus®
Crossref®
Google Scholar®
Publication Identifiers
Scopus: 2-s2.0-85051276943
Wos: WOS:000441233600009
Source Identifiers
ISSN: 0269-2813
Export Publication Metadata
Marked List
 Add to Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text
Full Text @ sfx.b-on.pt

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service